caprylates has been researched along with Disease Models, Animal in 45 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (15.56) | 18.7374 |
1990's | 4 (8.89) | 18.2507 |
2000's | 10 (22.22) | 29.6817 |
2010's | 14 (31.11) | 24.3611 |
2020's | 10 (22.22) | 2.80 |
Authors | Studies |
---|---|
Ma, S; Sun, Y; Yang, Y; Zheng, X | 1 |
Aghaei, Z; Cahill, LS; Jobst, KJ; Steeves, KL | 1 |
Amadio, S; Camponeschi, C; Clementi, ME; De Carluccio, M; Di Liddo, R; Di Sante, G; Michetti, F; Ria, F; Romano Spica, V; Sampaolese, B; Tredicine, M; Volonté, C | 1 |
Jiao, A; Liang, Y; Qin, J; Song, J; Yang, B | 1 |
Anderson, SE; Baur, R; Lukomska, E; Shane, HL; Weatherly, L | 1 |
Chang, S; Kleinschmidt, SE; Ley, CA; Olsen, GW; Parker, GA; Taiwo, OA | 1 |
Aristimunha, D; Cordeiro, JL; Gonçalves, CA; Netto, CA; Neves, JD; Pedroso, TA; Sanches, EF; Vizuete, AF | 1 |
Brites, G; Carrascal, MA; Cruz, MT; Moreira, P; Neves, B; Pereira, C; Pereira, M; Resende, R; Santos, AE; Silva, A; Silva, MM | 1 |
Altinoz, MA; Alturfan, AA; Cansız, D; Elmacı, İ; Emekli-Alturfan, E; Ünal, İ; Üstündağ, ÜV | 1 |
Imada, T; Nakamura, S; Tani, H; Tsubota, K; Yamaga, M; Yamaki, A | 1 |
Klaunig, JE; Li, X; Wang, Z | 1 |
Nakagawa, I; Nakase, H; Wajima, D; Yonezawa, T | 1 |
Baeg, MK; Choi, MG; Lim, CH; Park, H; Park, JM | 1 |
DeWitt, JC; Jiang, Q; Lust, RM | 1 |
Borges, K; Hodson, MP; McDonald, TS; Tan, KN | 1 |
Hanada, M; Imagama, S; Ishiguro, N; Matsuyama, Y; Miyagi, M; Shinjo, R; Sugiura, Y; Tsutsumi, K; Yasuda, T | 1 |
Bailey, M; Bellomo, R; Bertolini, J; Calzavacca, P; Ke, L; Li, WQ; May, CN | 1 |
Czuczwar, SJ; Gasior, M; Nieoczym, D; Socała, K; Wlaź, P; Żarnowska, I; Żarnowski, T | 1 |
Konnottil, R; Nair, RR; Saifudeen, I; Subhadra, L | 1 |
Benninghoff, AD; Carpenter, HM; Hendricks, JD; Orner, GA; Pereira, CB; Tilton, SC; Williams, DE | 1 |
Andres, T; Blei, MD; Cho, MD; Judy, R | 1 |
Aeed, H; Avni, Y; Didkovsky, E; Ilan, Y; Shahmurov, M; Shalev, T; Shirin, H; Sorin, V | 1 |
DeWitt, JC; Germolec, DR; Keller, JM; Peden-Adams, MM | 1 |
Brown, T; Dong, C; Hallett, M; Handforth, A; Haubenberger, D; Nahab, FB; Quesada, A; Shin, C | 1 |
Dai, K; Hoshikawa, M; Niwa, O; Okada, M; Saito, H; Suzuki, N; Yamamura, S | 1 |
Bilski, A; Cheng, A; Dzhun, A; Faravelli, I; Lange, D; Pasinetti, GM; Varghese, M; Vempati, P; Wang, J; Zhao, W | 1 |
Araki, T; Imai, Y; Itoyama, Y; Kato, H; Takahashi, A | 1 |
Hikosaka, K; Kaji, T; Kuge, Y; Nishijima, KC; Ohkura, K; Seki, K; Tamaki, N; Tsukamoto, E; Ueno, S | 1 |
Fujikawa, H; Iso, H; Mukasa, T; Nagata, T; Nishizaki, T; Tanaka, A; Yaguchi, T; Yamamoto, H; Yamamoto, S | 1 |
Manev, H; Manev, R | 1 |
Eriksson, P; Fredriksson, A; Johansson, N | 1 |
Ferenci, P; Jones, EA; Pappas, SC; Schafer, DF | 1 |
Trauner, DA | 1 |
Adams, H; Trauner, DA | 1 |
Crocker, JF; Her, H; Murphy, MG | 1 |
Horiuchi, M; Inoue, F; Kinugasa, A; Kizaki, Z; Kodo, N; Nakajima, T; Saheki, T; Sawada, T; Yamanaka, H | 1 |
Becedas, L; Bengtsson Ahlberg, M; Georgellis, A; Lundqvist, G; Mehrotra, K; Morgenstern, R | 1 |
Baughman, RA; Gonze, MD; Leone-Bay, A; Money, SR; Salartash, K; Sternbergh, WC | 1 |
Hasegawa, Y; Hashimoto, N; Hashimoto, T; Imanishi, M; Kawashima, H; Kuge, Y; Minematsu, K; Miyake, Y; Shiomi, M; Tamaki, N; Yamaguchi, T | 1 |
Money, SR; York, JW | 1 |
Hull, RD; Marder, VJ; Pineo, GF | 1 |
Danese, CA; Karipineni, RC; Wilk, PJ | 1 |
Drewes, LR; Leino, RL | 1 |
Danese, CA; Dreiling, DA; Georgalas-Penesis, M; Kirk, AE; Wastell, C | 1 |
Renaud, S | 1 |
5 review(s) available for caprylates and Disease Models, Animal
Article | Year |
---|---|
The impact of perfluoroalkyl substances on pregnancy, birth outcomes, and offspring development: a review of data from mouse models†.
Topics: Animals; Caprylates; Disease Models, Animal; Environmental Pollutants; Female; Fetal Development; Fluorocarbons; Mice; Placenta; Pregnancy | 2022 |
Brain edema in acute liver failure. Insight from experimental studies.
Topics: Animals; Brain Edema; Caprylates; Disease Models, Animal; Dogs; Galactosamine; Hepatectomy; Hepatic Artery; Hyperammonemia; Intracranial Hypertension; Ligation; Liver; Liver Failure; Portacaval Shunt, Surgical; Rabbits; Rats | 1990 |
Immunotoxicity of perfluorinated compounds: recent developments.
Topics: Alkanesulfonic Acids; Animals; Caprylates; Disease Models, Animal; Environmental Pollutants; Fluorocarbons; Humans; Immune System; Immunotoxins | 2012 |
Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis.
Topics: Administration, Oral; Anticoagulants; Antithrombin III; Biological Availability; Caprylates; Chemistry, Pharmaceutical; Decanoates; Disease Models, Animal; Drug Carriers; Drug Evaluation, Preclinical; Heparin; Humans; Hydroxybenzoates; Intestinal Absorption; Treatment Outcome; Venous Thrombosis | 2001 |
Orally active heparin and low-molecular-weight heparin.
Topics: Administration, Oral; Animals; Anticoagulants; Arthroplasty, Replacement, Hip; Caprylates; Disease Models, Animal; Drug Delivery Systems; Heparin; Heparin, Low-Molecular-Weight; Humans; Intestinal Absorption; Meta-Analysis as Topic; Thromboembolism | 2001 |
40 other study(ies) available for caprylates and Disease Models, Animal
Article | Year |
---|---|
Gastrodin attenuates perfluorooctanoic acid-induced liver injury by regulating gut microbiota composition in mice.
Topics: Animals; Benzyl Alcohols; Caprylates; Cecum; Cytokines; Disease Models, Animal; Fatty Acids, Volatile; Fluorocarbons; Gastrointestinal Microbiome; Glucosides; Hepatomegaly; Inflammation Mediators; Liver; Male; Mice, Inbred C57BL; Oxidative Stress; Phylogeny; Protective Agents | 2021 |
S100B Protein as a Therapeutic Target in Multiple Sclerosis: The S100B Inhibitor Arundic Acid Protects from Chronic Experimental Autoimmune Encephalomyelitis.
Topics: Animals; Caprylates; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Mice; Mice, Inbred C57BL; Molecular Targeted Therapy; Multiple Sclerosis; S100 Calcium Binding Protein beta Subunit | 2021 |
In Silico Analysis Identifies the Anti-Liver Injury Targets of Diammonium Glycyrrhizinate: Validated in Perfluorooctanoic Acid-Lesioned Mouse Model.
Topics: Animals; Caprylates; Caspase 3; Chemical and Drug Induced Liver Injury, Chronic; Cyclooxygenase 2; Disease Models, Animal; Fluorocarbons; Glycyrrhizic Acid; Mice; Molecular Docking Simulation | 2022 |
Immunotoxicity and allergenic potential induced by topical application of perfluorooctanoic acid (PFOA) in a murine model.
Topics: Allergens; Animals; Antibody Formation; Caprylates; Disease Models, Animal; Erythrocytes; Female; Fluorocarbons; Mice; Mice, Inbred BALB C; Models, Animal; Sheep; Skin; Spleen; Thymus Gland | 2020 |
A Pathology Review of the Lower Gastrointestinal Tract in Relation to Ulcerative Colitis in Rats and Cynomolgus Macaques Treated With Ammonium Perfluorooctanoate.
Topics: Animals; Caprylates; Colitis, Ulcerative; Disease Models, Animal; Female; Fluorocarbons; Humans; Lower Gastrointestinal Tract; Macaca fascicularis; Male; Ohio; Rats; Rats, Sprague-Dawley; Rivers; Toxicity Tests; Water Pollutants, Chemical | 2020 |
Arundic Acid (ONO-2506), an Inhibitor of S100B Protein Synthesis, Prevents Neurological Deficits and Brain Tissue Damage Following Intracerebral Hemorrhage in Male Wistar Rats.
Topics: Animals; Brain Injuries; Caprylates; Cerebral Hemorrhage; Disease Models, Animal; Male; Neuroprotective Agents; Rats; Rats, Wistar; S100 Calcium Binding Protein beta Subunit | 2020 |
Calcium Modulation, Anti-Oxidant and Anti-Inflammatory Effect of Skin Allergens Targeting the Nrf2 Signaling Pathway in Alzheimer's Disease Cellular Models.
Topics: Allergens; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Calcium; Caprylates; Cell Line; Disease Models, Animal; Heme Oxygenase-1; Humans; Membrane Proteins; Mice; Microglia; NF-E2-Related Factor 2; Phenylenediamines; Skin | 2020 |
Caprylic acid ameliorates rotenone induced inflammation and oxidative stress in the gut-brain axis in Zebrafish.
Topics: Animals; Brain; Brain-Gut Axis; Caprylates; Disease Models, Animal; Gastrointestinal Tract; Glutathione; Inflammation; Lipid Peroxidation; Oxidative Stress; Parkinson Disease; Rotenone; Superoxide Dismutase; Zebrafish; Zebrafish Proteins | 2021 |
Acetylcholine and Royal Jelly Fatty Acid Combinations as Potential Dry Eye Treatment Components in Mice.
Topics: Acetylcholine; Animals; Caprylates; Decanoic Acids; Disease Models, Animal; Drug Therapy, Combination; Dry Eye Syndromes; Fatty Acids; Mice; Tears | 2021 |
The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.
Topics: Animals; Caprylates; Cell Proliferation; Chemical and Drug Induced Liver Injury; Constitutive Androstane Receptor; Cytochrome P-450 Enzyme System; Diet, High-Fat; Disease Models, Animal; Disease Progression; Environmental Pollutants; Fluorocarbons; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; PPAR alpha; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Risk Assessment; Signal Transduction; Time Factors | 2019 |
Neuroprotective effect of suppression of astrocytic activation by arundic acid on brain injuries in rats with acute subdural hematomas.
Topics: Analysis of Variance; Animals; Aquaporin 4; Astrocytes; bcl-2-Associated X Protein; Brain Edema; Brain Infarction; Brain Injuries; Caprylates; Cell Count; Disease Models, Animal; Hematoma, Subdural, Acute; In Situ Nick-End Labeling; Male; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; S100 Proteins; Time Factors | 2013 |
Effect of DA-9701 on gastric emptying in a mouse model: assessment by ¹³C-octanoic acid breath test.
Topics: Animals; Body Weight; Breath Tests; Caprylates; Carbon Isotopes; Cross-Over Studies; Disease Models, Animal; Erythromycin; Gastric Emptying; Gastrointestinal Agents; Male; Mice; Mice, Inbred C57BL; Plant Preparations; Random Allocation; Reproducibility of Results; Time Factors | 2013 |
Perfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved?
Topics: Animals; Biomarkers; Bone Morphogenetic Protein 2; Caprylates; Chick Embryo; Disease Models, Animal; Embryo, Nonmammalian; Environmental Pollutants; Fetal Heart; Fluorocarbons; Gene Expression Regulation, Developmental; Heart Defects, Congenital; Heart Ventricles; Myocardium; Peroxisome Proliferators; PPAR alpha; Pyrimidines; Smad Proteins | 2013 |
Alterations of hippocampal glucose metabolism by even versus uneven medium chain triglycerides.
Topics: Animals; Anticonvulsants; Caprylates; Citric Acid Cycle; Disease Models, Animal; Energy Metabolism; Glucose; Hippocampus; Male; Mice; Mice, Inbred Strains; Seizures; Structure-Activity Relationship; Triglycerides | 2014 |
Arundic acid (ONO-2506) inhibits secondary injury and improves motor function in rats with spinal cord injury.
Topics: Animals; Caprylates; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Kaplan-Meier Estimate; Movement Disorders; Muscle Strength; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries; Time Factors; Tubulin | 2014 |
Systemic and renal haemodynamic effects of fluid bolus therapy: sodium chloride versus sodium octanoate-balanced solution.
Topics: Animals; Caprylates; Critical Illness; Disease Models, Animal; Fluid Therapy; Hemodynamics; Infusions, Intravenous; Regional Blood Flow; Renal Circulation; Sheep; Sodium Chloride | 2014 |
Acute anticonvulsant effects of capric acid in seizure tests in mice.
Topics: 3-Hydroxybutyric Acid; Animals; Anticonvulsants; Blood Glucose; Brain; Caprylates; Decanoic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Hydrogen-Ion Concentration; Male; Mice; Motor Skills; Seizures | 2015 |
Metabolic Modulation by Medium-Chain Triglycerides Reduces Oxidative Stress and Ameliorates CD36-Mediated Cardiac Remodeling in Spontaneously Hypertensive Rat in the Initial and Established Stages of Hypertrophy.
Topics: Animals; Blood Pressure; Caprylates; CD36 Antigens; Dietary Supplements; Disease Models, Animal; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Inbred SHR; Triglycerides; Ventricular Remodeling | 2017 |
Genomic profiling reveals an alternate mechanism for hepatic tumor promotion by perfluorooctanoic acid in rainbow trout.
Topics: Aflatoxin B1; Animals; Caprylates; Carcinogenicity Tests; Clofibrate; Cluster Analysis; Dehydroepiandrosterone; Disease Models, Animal; Estradiol; Fluorocarbons; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Oncorhynchus mykiss; Peroxisomes; Signal Transduction | 2008 |
Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models.
Topics: Acetamides; Acute Disease; Animals; Breath Tests; Caprylates; Carbon Dioxide; Carbon Isotopes; Chemical and Drug Induced Liver Injury; Cholestasis, Extrahepatic; Common Bile Duct; Disease Models, Animal; Ligation; Liver; Liver Cirrhosis, Experimental; Male; Predictive Value of Tests; Rats; Rats, Wistar; Thioacetamide; Time Factors | 2010 |
Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor.
Topics: Animals; Caprylates; Central Nervous System Stimulants; Disease Models, Animal; Dose-Response Relationship, Drug; Essential Tremor; Harmaline; Male; Mice; Mice, Inbred ICR | 2012 |
ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation.
Topics: Animals; Anticonvulsants; Astrocytes; Caprylates; Cells, Cultured; Convulsants; Disease Models, Animal; Electroshock; Epilepsy; gamma-Aminobutyric Acid; Glutamic Acid; Kynurenic Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pentylenetetrazole; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serine; Synaptic Transmission | 2013 |
Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease.
Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Caprylates; Disease Models, Animal; Energy Metabolism; Humans; Ketones; Mice; Mitochondria; Motor Neurons; Oxygen Consumption; Spinal Cord; Superoxide Dismutase; Triglycerides | 2012 |
Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Astrocytes; Caprylates; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2003 |
Characteristic brain distribution of 1-(14)C-octanoate in a rat model of focal cerebral ischemia in comparison with those of (123)I-IMP and (123)I-iomazenil.
Topics: Animals; Autoradiography; Brain; Brain Ischemia; Caprylates; Disease Models, Animal; Flumazenil; Iofetamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2003 |
Linoleic acid derivative DCP-LA improves learning impairment in SAMP8.
Topics: Aging; Animals; Avoidance Learning; Behavior, Animal; Caprylates; Disease Models, Animal; Exploratory Behavior; Learning Disabilities; Linoleic Acid; Male; Maze Learning; Mice; Mice, Neurologic Mutants; Motor Activity; Reaction Time | 2006 |
Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?
Topics: Alzheimer Disease; Animals; Caprylates; Clinical Trials as Topic; Comorbidity; Depression; Disease Models, Animal; Fluoxetine; Humans; Nerve Growth Factors; Neuroprotective Agents; Risk Factors; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stroke | 2006 |
Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice.
Topics: Alkanesulfonic Acids; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Brain Diseases; Caprylates; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Fluorocarbons; Locomotion; Male; Maze Learning; Mental Disorders; Mice; Nicotine; Nicotinic Agonists; Pregnancy; Time Factors | 2008 |
Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
Topics: Ammonia; Animals; Caprylates; Disease Models, Animal; Disulfides; Evoked Potentials, Visual; Galactosamine; Hepatic Encephalopathy; Rabbits; Seizures | 1984 |
Pathologic changes in a rabbit model of Reye's syndrome.
Topics: Animals; Brain; Caprylates; Disease Models, Animal; Hemodynamics; Liver; Male; Rabbits; Reye Syndrome | 1982 |
Intracranial pressure elevations during octanoate infusion in rabbits: an experimental model of Reye's syndrome.
Topics: Animals; Caprylates; Disease Models, Animal; Intracranial Pressure; Male; Paralysis; Rabbits; Reye Syndrome | 1981 |
Abnormalities in hepatic fatty-acid metabolism in a surfactant/influenza B virus mouse model for acute encephalopathy.
Topics: Adenosine Triphosphate; Administration, Cutaneous; Animals; Caprylates; Disease Models, Animal; Emulsions; Fatty Acids; Female; Hepatic Encephalopathy; Humans; Influenza B virus; Influenza, Human; Lipid Peroxidation; Liver; Male; Mice; Organic Chemicals; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Reye Syndrome; Surface-Active Agents; Thiobarbituric Acid Reactive Substances | 1996 |
The effect of carnitine on ketogenesis in perfused livers from juvenile visceral steatosis mice with systemic carnitine deficiency.
Topics: Animals; Butyrates; Butyric Acid; Caprylates; Carnitine; Disease Models, Animal; Fatty Liver; In Vitro Techniques; Ketone Bodies; Liver; Mice; Mice, Mutant Strains; Oleic Acid; Perfusion | 1997 |
Effects of peroxisome proliferators and/or hypothyroidism on xenobiotic-metabolizing enzymes in rat testis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arylsulfotransferase; Aspirin; Caprylates; Catalase; Clofibrate; Diet; Diethylhexyl Phthalate; Disease Models, Animal; Epoxide Hydrolases; Fluorocarbons; Glucuronosyltransferase; Glutathione Peroxidase; Glutathione Transferase; Hypolipidemic Agents; Hypothyroidism; Male; Microbodies; NAD(P)H Dehydrogenase (Quinone); Rats; Rats, Sprague-Dawley; Testis | 1997 |
Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.
Topics: Administration, Oral; Animals; Anticoagulants; Caprylates; Disease Models, Animal; Drug Carriers; Enoxaparin; Injections, Subcutaneous; Jugular Veins; Male; Partial Thromboplastin Time; Rats; Rats, Sprague-Dawley; Venous Thrombosis | 2000 |
[1-11C]Octanoate as a PET tracer for studying ischemic stroke: evaluation in a canine model of thromboembolic stroke with positron emission tomography.
Topics: Animals; Caprylates; Cerebrovascular Circulation; Disease Models, Animal; Dogs; Male; Radiopharmaceuticals; Thromboembolism; Tomography, Emission-Computed | 2000 |
Failure of intestinal lymphatic block to prevent experimental hypercholesterolemia.
Topics: Animals; Caprylates; Disease Models, Animal; Dogs; Hypercholesterolemia; Intestinal Absorption; Intestine, Small; Ligation; Lymphatic System; Oleic Acids | 1975 |
Neuron-specific mitochondrial degeneration induced by hyperammonemia and octanoic acidemia.
Topics: Ammonia; Animals; Brain; Caprylates; Disease Models, Animal; Dogs; In Vitro Techniques; Mitochondria; Nerve Degeneration; Reye Syndrome | 1985 |
Studies of the effects of blockade of intestinal lymphatics. II. Metabolic considerations.
Topics: Autoradiography; Caprylates; Disease Models, Animal; Fatty Acids; Intestinal Absorption; Intestinal Diseases; Ligation; Lymphatic System; Lymphedema; Oleic Acids; Serum Albumin, Radio-Iodinated; Triglycerides; Xylose | 1972 |
Thrombotic, atherosclerotic and lipemic effects of dietary fats in the rat.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Butter; Cacao; Caprylates; Cocos; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Fatty Acids; Hyperlipidemias; Linoleic Acids; Liver; Male; Oils; Oleic Acids; Palmitic Acids; Rats; Stearic Acids; Thrombosis; Triglycerides | 1969 |